Thrombosis and Complement BLOOD-DEVICE INTERACTIONS.
-
Upload
shanon-washington -
Category
Documents
-
view
217 -
download
0
Transcript of Thrombosis and Complement BLOOD-DEVICE INTERACTIONS.
![Page 1: Thrombosis and Complement BLOOD-DEVICE INTERACTIONS.](https://reader036.fdocuments.net/reader036/viewer/2022062515/56649cef5503460f949bd100/html5/thumbnails/1.jpg)
Thrombosis and Complement
BLOOD-DEVICE INTERACTIONS
![Page 2: Thrombosis and Complement BLOOD-DEVICE INTERACTIONS.](https://reader036.fdocuments.net/reader036/viewer/2022062515/56649cef5503460f949bd100/html5/thumbnails/2.jpg)
CARDIAC VALVES AND VASCULAR GRAFTSThrombosis
![Page 3: Thrombosis and Complement BLOOD-DEVICE INTERACTIONS.](https://reader036.fdocuments.net/reader036/viewer/2022062515/56649cef5503460f949bd100/html5/thumbnails/3.jpg)
Taxol stent thrombosis(late stage thrombosis related to TissueFactor generation-see later slide)
![Page 4: Thrombosis and Complement BLOOD-DEVICE INTERACTIONS.](https://reader036.fdocuments.net/reader036/viewer/2022062515/56649cef5503460f949bd100/html5/thumbnails/4.jpg)
CLINICAL MANIFESTATIONS• Thrombotic events can range between 2% and 10% depending upon the device
• Sudden and complete obstruction within weeks
• Sub-acute thrombotic occlusion
• Long-term “chronic” thrombosis
• Embolism
![Page 5: Thrombosis and Complement BLOOD-DEVICE INTERACTIONS.](https://reader036.fdocuments.net/reader036/viewer/2022062515/56649cef5503460f949bd100/html5/thumbnails/5.jpg)
THROMBOSIS-WHY?
• Vascular grafts• Midgraft thrombosis
• Lack of endothelium
• Intimal narrowing at anastamosis
• Surgical trauma
• Variations in flow
• Low flow-augmentation of anastomotic intimal hyperplasia
• Shear stress
• Diameter mismatches
![Page 6: Thrombosis and Complement BLOOD-DEVICE INTERACTIONS.](https://reader036.fdocuments.net/reader036/viewer/2022062515/56649cef5503460f949bd100/html5/thumbnails/6.jpg)
Figure 11b. Stent-graft thrombosis after therapy with a bifurcated graft.
Tillich M et al. Radiographics 1999;19:1573-1583
Figure 11b. Stent-graft thrombosis after therapy with a bifurcated graft. (a) Axial helical CT scan of the midgraft region obtained 5 months after therapy shows a crescent-shaped, parietal thrombus adjacent to the left wall of the stent-graft (arrowheads) extending distally into the left graft limb. (b) Photograph of the surgical specimen shows the thrombus adjacent to the left wall of the stent-graft (arrowheads). (c) Axial helical CT scan obtained at the level of the graft limbs shows complete thrombosis of the left graft limb (arrow).
![Page 7: Thrombosis and Complement BLOOD-DEVICE INTERACTIONS.](https://reader036.fdocuments.net/reader036/viewer/2022062515/56649cef5503460f949bd100/html5/thumbnails/7.jpg)
Small diameter vascular grafts are most prone to coagulation and occlusion
![Page 8: Thrombosis and Complement BLOOD-DEVICE INTERACTIONS.](https://reader036.fdocuments.net/reader036/viewer/2022062515/56649cef5503460f949bd100/html5/thumbnails/8.jpg)
THROMBOSIS-WHY?
• Cardiac Valves• Intimal narrowing at anastamosis
• Surgical trauma
• Lack of endothelium
• Variations in flow and turbulence
• Shear stress
• Diameter mismatches
![Page 9: Thrombosis and Complement BLOOD-DEVICE INTERACTIONS.](https://reader036.fdocuments.net/reader036/viewer/2022062515/56649cef5503460f949bd100/html5/thumbnails/9.jpg)
Mechanical mitral valve with pannus obstructing the leaflet.
Imran U H et al. BMJ Case Reports 2011;2011:bcr.03.2011.3969
©2011 by BMJ Publishing Group Ltd
![Page 10: Thrombosis and Complement BLOOD-DEVICE INTERACTIONS.](https://reader036.fdocuments.net/reader036/viewer/2022062515/56649cef5503460f949bd100/html5/thumbnails/10.jpg)
Heart 2009;95:430-436 doi:10.1136/hrt.2007.134726
![Page 11: Thrombosis and Complement BLOOD-DEVICE INTERACTIONS.](https://reader036.fdocuments.net/reader036/viewer/2022062515/56649cef5503460f949bd100/html5/thumbnails/11.jpg)
THE INITIAL STEPS…(PLATELET ACTIVATION)
• Exposure of biomaterial surface or platelet trauma
• Initiation of the clotting cascade automatically initiates wound healing (soft tissue lecture)
• Binding of Factor XII
• Activation of platelets and release of phospholipids and platelet factor 3
• Activation of Factor X
• Culimination in common pathway
• Fibrin clot formed from bound and circulating fibrinogen
Contact phase proteins
![Page 12: Thrombosis and Complement BLOOD-DEVICE INTERACTIONS.](https://reader036.fdocuments.net/reader036/viewer/2022062515/56649cef5503460f949bd100/html5/thumbnails/12.jpg)
Factor XII activated by binding to material
HMW-Kininogen activated by binding to material
This is more prevalent in early dialysis membranes (and ECMO)
This is more prevalent in vasculargrafts
![Page 13: Thrombosis and Complement BLOOD-DEVICE INTERACTIONS.](https://reader036.fdocuments.net/reader036/viewer/2022062515/56649cef5503460f949bd100/html5/thumbnails/13.jpg)
INCREASED ACTIVATION OF FACTOR XIIFACTOR XIIA ACTIVATES FACTOR XI
This is directly related to the thrombogenicity of the vascular graft material
Theory I
http://www.hopkinsmedicine.org/hematology/coagulation.swf
![Page 14: Thrombosis and Complement BLOOD-DEVICE INTERACTIONS.](https://reader036.fdocuments.net/reader036/viewer/2022062515/56649cef5503460f949bd100/html5/thumbnails/14.jpg)
Activation of blood monocytes resulting from device –related inflammation may result in the release of TF. TF release may then lead to coagulation along the extrinsic pathway.
Relationships between inflammation and coagulation?
Theory II
![Page 15: Thrombosis and Complement BLOOD-DEVICE INTERACTIONS.](https://reader036.fdocuments.net/reader036/viewer/2022062515/56649cef5503460f949bd100/html5/thumbnails/15.jpg)
![Page 16: Thrombosis and Complement BLOOD-DEVICE INTERACTIONS.](https://reader036.fdocuments.net/reader036/viewer/2022062515/56649cef5503460f949bd100/html5/thumbnails/16.jpg)
CONTROL POINTS
• Calcium• Calcium chelators
• Thrombin• Key in common pathway and
feedback loops
• Platelets• Adherence to biomaterials
![Page 17: Thrombosis and Complement BLOOD-DEVICE INTERACTIONS.](https://reader036.fdocuments.net/reader036/viewer/2022062515/56649cef5503460f949bd100/html5/thumbnails/17.jpg)
CONTROL OF COAGULATIONFIBRINOLYSIS AND ANTICOAGULANTS
tpa-tissue plasminogen activator
![Page 18: Thrombosis and Complement BLOOD-DEVICE INTERACTIONS.](https://reader036.fdocuments.net/reader036/viewer/2022062515/56649cef5503460f949bd100/html5/thumbnails/18.jpg)
The Intersection Between Coagulation and Complement Activation
![Page 19: Thrombosis and Complement BLOOD-DEVICE INTERACTIONS.](https://reader036.fdocuments.net/reader036/viewer/2022062515/56649cef5503460f949bd100/html5/thumbnails/19.jpg)
DIALYSIS MEMBRANES/ECMOComplement Activation
![Page 20: Thrombosis and Complement BLOOD-DEVICE INTERACTIONS.](https://reader036.fdocuments.net/reader036/viewer/2022062515/56649cef5503460f949bd100/html5/thumbnails/20.jpg)
COMPLEMENT ACTIVATIONHTTP://HIGHERED.MCGRAW-HILL.COM/SITES/0072507470/STUDENT_VIEW0/CHAPTER22/ANIMATION__ACTIVATION_OF_COMPLEMENT.HTML
![Page 21: Thrombosis and Complement BLOOD-DEVICE INTERACTIONS.](https://reader036.fdocuments.net/reader036/viewer/2022062515/56649cef5503460f949bd100/html5/thumbnails/21.jpg)
COMPLEMENT ACTIVATION AND RENAL DIALYSIS/ECMO (THEORY 1)
Complement regulatory proteins in glomerular diseasesMasaomi Nangaku
Neutrophil activationNeutropeniaIncreased conc. Ofdegradative enzymesReactive oxygen species
Generation of arachidonic acidmetabolites and cytokinesPulmonary hypertension
O-C3b/C5 C5a
Factor XII/Thrombin binding and proteolysis of C3 followed by C3bbinding
![Page 22: Thrombosis and Complement BLOOD-DEVICE INTERACTIONS.](https://reader036.fdocuments.net/reader036/viewer/2022062515/56649cef5503460f949bd100/html5/thumbnails/22.jpg)
Rapid activation of the complement system by cuprophane depends on complement component C4Karl Lhotta, Reinhard Würzner, Florian Kronenberg, Martin Oppermann and Paul König
RegeneratedCellulose(Cuprophan)
Theory 2
Fibrinogen and C4b2a binding to material (along with albumin) activateconversion of C3 into C3a and C3b
![Page 23: Thrombosis and Complement BLOOD-DEVICE INTERACTIONS.](https://reader036.fdocuments.net/reader036/viewer/2022062515/56649cef5503460f949bd100/html5/thumbnails/23.jpg)
Thrombosis and Complement: Crosstalk
![Page 24: Thrombosis and Complement BLOOD-DEVICE INTERACTIONS.](https://reader036.fdocuments.net/reader036/viewer/2022062515/56649cef5503460f949bd100/html5/thumbnails/24.jpg)
Cleavage of C3 results in formation of C3a and C3b resulting in amplification of C3activation and also C5 conversion to C5a and C5b
![Page 25: Thrombosis and Complement BLOOD-DEVICE INTERACTIONS.](https://reader036.fdocuments.net/reader036/viewer/2022062515/56649cef5503460f949bd100/html5/thumbnails/25.jpg)
![Page 26: Thrombosis and Complement BLOOD-DEVICE INTERACTIONS.](https://reader036.fdocuments.net/reader036/viewer/2022062515/56649cef5503460f949bd100/html5/thumbnails/26.jpg)
THE HOST’S RESPONSE• Protein deposition on membrane
• Boundary layer/secondary layer
• Cellular Activation
• Platelet/leukocyte aggregates
• Immune stimulation
• Complement
• Hypersensitivity reactions
• Residual ETO
• Hemodynamic Effects• Contact phase formation of bradykinin
![Page 27: Thrombosis and Complement BLOOD-DEVICE INTERACTIONS.](https://reader036.fdocuments.net/reader036/viewer/2022062515/56649cef5503460f949bd100/html5/thumbnails/27.jpg)
PROTEIN DEPOSITION• Deposition of protein occurs instantaneously
• A protein layer forms on the surface of the membrane as the levels of solution phase proteins increase
• Composition of adsorbed proteins depends upon membrane type
• Hydrophobic membranes tend to adsorb more proteins
• Proteins adsorb and then detach until permanent adsorption and denaturing occurs
• This may result in the formation of a boundary layer
• Protein adsorption determines cellular responses
• Protein adsorption may serve as a way to successfully remove unwanted proteins from patients or may negatively effect the diffusivity of the membrane
• Low MW-interleukins, inflammatory cytokines
• High MW-albumin, fibrinogen, IgG
![Page 28: Thrombosis and Complement BLOOD-DEVICE INTERACTIONS.](https://reader036.fdocuments.net/reader036/viewer/2022062515/56649cef5503460f949bd100/html5/thumbnails/28.jpg)
• Platelets aggregate on membrane surface resulting in further aggregation of leukocytes
• Aggregation causes activation of the platelets as well as the leukocytes and can result in release of platelet-derived factors and cytokines
• Results: superoxide release, cytokine release and leukopenia
• Superoxide release resulting from chronic dialysis has been implicated in atherosclerosis
• Cytokine release and leukopenia can result in general feeling of malaise
PLATELET/LEUKOCYTE AGGREGATES
UPenn
![Page 29: Thrombosis and Complement BLOOD-DEVICE INTERACTIONS.](https://reader036.fdocuments.net/reader036/viewer/2022062515/56649cef5503460f949bd100/html5/thumbnails/29.jpg)
HYPERSENSITIVITY AND HEMODYNAMICS“First use syndrome”-Inflammation and Hypersensitivity
Toxins-ETO (sterilization) residuals
Plasticizers-Membrane mfg
Leachables-Membrane mfg
Post-perfusion syndrome (neucleophiles)Contact phase activation
Bradykinin is formed due to contact with the membraneBradykinin system activated by Factor XII (clotting cascade)
VasodilationAnaphylaxis
![Page 30: Thrombosis and Complement BLOOD-DEVICE INTERACTIONS.](https://reader036.fdocuments.net/reader036/viewer/2022062515/56649cef5503460f949bd100/html5/thumbnails/30.jpg)
POST-PERFUSION SYNDROMECONTACT PHASE ACTIVATION
BRADYKININ GENERATIONPOTENTIATION BY ACE INHIBITORS
Systemic inflammatory responseAcute lung failureSepsisMulti-organ failure